Southland Equity Partners LLC lifted its stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 26.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 3,881 shares of the company’s stock after purchasing an additional 813 shares during the period. Southland Equity Partners LLC’s holdings in Colgate-Palmolive were worth $353,000 at the end of the most recent reporting period.
Other hedge funds have also made changes to their positions in the company. Reston Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the third quarter valued at approximately $42,000. Capital Performance Advisors LLP acquired a new position in shares of Colgate-Palmolive during the third quarter valued at approximately $53,000. Prospera Private Wealth LLC acquired a new position in shares of Colgate-Palmolive during the third quarter valued at approximately $64,000. True Wealth Design LLC increased its stake in shares of Colgate-Palmolive by 1,460.9% during the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after acquiring an additional 672 shares during the period. Finally, Continuum Advisory LLC increased its stake in shares of Colgate-Palmolive by 93.4% during the third quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock valued at $79,000 after acquiring an additional 368 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of brokerages recently weighed in on CL. Barclays reduced their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Stifel Nicolaus reduced their target price on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a report on Friday, January 17th. UBS Group reduced their target price on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a report on Thursday, January 16th. Piper Sandler reduced their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. Finally, Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $101.11.
Insider Transactions at Colgate-Palmolive
In other news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.34% of the company’s stock.
Colgate-Palmolive Stock Performance
NYSE:CL opened at $87.98 on Friday. The firm’s 50-day moving average is $92.00 and its 200-day moving average is $97.58. Colgate-Palmolive has a 52-week low of $80.03 and a 52-week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The company has a market cap of $71.88 billion, a price-to-earnings ratio of 25.21, a PEG ratio of 3.59 and a beta of 0.44.
Colgate-Palmolive Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.27%. Colgate-Palmolive’s payout ratio is 57.31%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- How to trade using analyst ratings
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- 3 Dividend Kings To Consider
- 3 Buy-and-Hold Stocks for Long-Term Growth
- The 3 Best Retail Stocks to Shop for in August
- Despite Short-Term Risks Freeport McMoran Worth a Look
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.